Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. - Wikidata - awgldk - TriplyDB

Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.

Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.

http://www.wikidata.org/entity/Q40443041

about

MST1 is a multifunctional caspase-independent inhibitor of androgenic signaling.Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate Cancer Modulators of prostate cancer cell proliferation and viability identified by short-hairpin RNA library screening Restoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors.SIRNA-directed in vivo silencing of androgen receptor inhibits the growth of castration-resistant prostate carcinomas.Transcription factor and microRNA regulation in androgen-dependent and -independent prostate cancer cells.MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signaling Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.Rapamycin selectively reduces the association of transcripts containing complex 5' UTRs with ribosomes in C4-2B prostate cancer cells.Prolonging hormone sensitivity in prostate cancer xenografts through dual inhibition of AR and mTOR.Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expression Association between cannabinoid CB₁ receptor expression and Akt signalling in prostate cancer.Androgen Receptor regulation of Vitamin D receptor in response of castration-resistant prostate cancer cells to 1α-Hydroxyvitamin D5 - a calcitriol analog.Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block.Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3 Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor Signaling mechanisms coupled to CXCL12/CXCR4-mediated cellular proliferation are PTEN-dependent.Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer Structure-based virtual screening and identification of a novel androgen receptor antagonist.Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression Sensitivity and mechanisms of taxol-resistant prostate adenocarcinoma cells to Vernonia amygdalina extract Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer AKT upregulates B-Raf Ser445 phosphorylation and ERK1/2 activation in prostate cancer cells in response to androgen depletion.Akt Activation Correlates with Snail Expression and Potentially Determines the Recurrence of Prostate Cancer in Patients at Stage T2 after a Radical Prostatectomy.Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival.DNA methylome changes by estradiol benzoate and bisphenol A links early-life environmental exposures to prostate cancer risk Non-Genomic Actions of the Androgen Receptor in Prostate Cancer Anticancer activities of artemisinin and its bioactive derivatives.Safety and preliminary efficacy analysis of the mTOR inhibitor ridaforolimus in patients with taxane-treated, castration-resistant prostate cancer.Interleukin-6: a multifunctional targetable cytokine in human prostate cancer.The hurdle of antiandrogen drug resistance: drug design strategies.Knockdown of VEGFR2 inhibits proliferation and induces apoptosis in hemangioma-derived endothelial cells.Antibody targeting of HER2/HER3 signaling overcomes heregulin-induced resistance to PI3K inhibition in prostate cancer.Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase/Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20-like kinase 1.Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers.Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.

P2860

Q24300132-8B9D733A-68CB-4D20-9A99-4E3191AFD983 Q28382812-E18369B3-0B75-46C6-9D72-2C3040F9B45F Q28388072-A072AA31-793B-4385-A2AE-EFA4204FD3CC Q28482249-384D0994-203D-43DE-9CFB-AC7923FE353F Q30438487-83DFEA4B-F48E-4F48-86E5-BCA8BA578273 Q33302103-B5906DB3-4FF9-4FDB-B0A2-9F5C2F466FB6 Q33373567-73FE23F0-ACE7-4382-8E95-269E31F4140F Q33443571-3BA63700-7561-4F93-B2FC-117453C12129 Q33651942-ED60442F-E7AF-4621-85A8-E9C3CFCE5B78 Q34001080-CE724CAD-2931-4FE1-8BC4-74EC24630F71 Q34033097-2F4DADC0-0299-40B2-AD9F-02F76E24325B Q34250227-9BF1490B-126F-47D4-9657-3AFD086EF87C Q34469245-CF7BE9D5-A13A-4AE4-BFEE-C4C1F8F80CD3 Q34766747-EBF2D688-ED6B-44C7-8E1A-9A2F6D6A1F84 Q34943321-5CBC45EE-34F6-46E0-872E-1511557FFC1C Q34985562-738B200C-FB3C-437B-B207-3080510F9149 Q35269318-BFF473F6-3229-4BCA-9DC9-42A3815F7085 Q35611347-4A30AA09-0D67-4048-B197-AC165B2E4316 Q35838409-E113D0FC-6BCC-411C-9B08-C77A0B2F8B26 Q35962850-2C3857CE-3114-4FB6-B6B6-4D3B76DFF683 Q36199762-02DCC065-1828-4ABB-8B22-8A6918533A46 Q36216496-E1279CE3-1EEE-4326-8984-47476269F32C Q36517940-FC24D81E-E934-4354-BA73-6B2CB69C3C14 Q36557452-C9747766-E6D5-43FE-85BF-345CF26CB84A Q36840555-0A319161-D7FD-40B1-9592-31413999643C Q36919879-0A7C1675-7622-4189-B64D-BE1B4B56B3E3 Q36977833-98D29B4D-4530-46E9-AF54-AC203D405C73 Q37209816-B97D2A36-3CE4-4B05-A3AA-0A7EB5929B21 Q37221646-1E74B8FB-E4E9-47FA-A276-568828763AF4 Q37308114-821E2858-4CED-49A9-835F-0A8E0C49DB45 Q37588620-372F4E31-1D79-4493-BD1A-83B67C6E1758 Q37626137-1FF136B6-BD40-4EF3-A7DF-FD7993025874 Q37658520-0CE0DDB0-A2D2-4B85-B6A7-74D10011AE3A Q37888027-015370B7-5CD3-4CAF-9E0A-90A82D6344E8 Q38160927-DC9AB9BE-099D-4A0D-AFF6-1D451DAA7505 Q38667341-0410C6E4-D814-4DF0-8308-1B981C696E64 Q38932495-48957DD4-F3E1-4FE0-A363-1A451922EF94 Q39343934-31C41713-0FAC-4A75-988C-96FCEEB6886B Q39550412-C9163EF5-DF53-4407-8C01-431331CD8A8A Q39664750-6300C864-9A1F-4CBB-B169-5FC4638AA277

P2860

Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.

http://www.wikidata.org/entity/Q40443041

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Signal transduction pathways i ...... ate cancer cell proliferation.

@en

type

label

Signal transduction pathways i ...... ate cancer cell proliferation.

@en

prefLabel

Signal transduction pathways i ...... ate cancer cell proliferation.

@en

P1433

Q40443041-B54986B1-ADB3-4E6A-A9EF-2EB5EA1727BE

P1476

Q40443041-22DD66CD-E81A-447E-9CD6-452DE6E31E22

P2093

Q40443041-30189F6E-F871-4DB5-ADAA-7D9276371544

Q40443041-327DFC37-41CB-40E4-836B-2FCB5D6C0CC5

Q40443041-3586C749-00F2-4D50-BCA9-1974F7BAB9DB

Q40443041-4615ACFE-8B36-48AA-B844-E87D78CF0B39

Q40443041-54E4E8BB-4811-41C8-AF2D-2305AEF0F7D7

Q40443041-5CDD2559-038C-4A16-B8B8-0BCEE8B5D5ED

Q40443041-70829689-70EB-4CCB-BC23-1C1A103CF103

Q40443041-D5E14283-1345-4B31-B893-50D7CAA1A985

P304

Q40443041-30B7801D-52DC-49B5-B0AE-8C32D0A3426D

P31

Q40443041-1AC75E1C-2F4D-4A7A-B31C-B3F632388207

P356

Q40443041-C9AE6775-85ED-4A34-9F6C-9017D82ABF52

P433

Q40443041-63314A7F-0575-445F-B2C6-AA6FD9EAD920

P478

Q40443041-7C086E1D-C9F1-4E36-92E3-B4D24BC2932C

P577

Q40443041-305F04CC-7B6F-4DAD-A2FC-92DE9226EBEF

P5875

Q40443041-ED2823E5-1C7A-4B09-89A5-3C9B4F754C1B

P698

Q40443041-91EB1DB6-EADF-465D-A27A-6C66F43A2FD8

P356

P1433

Endocrine-related cancer

P1476

Signal transduction pathways i ...... ate cancer cell proliferation.

@en

P2093

Dean A Troyer

http://www.w3.org/2001/XMLSchema#string

Jeffrey I Kreisberg

http://www.w3.org/2001/XMLSchema#string

Margarita Mikhailova

http://www.w3.org/2001/XMLSchema#string

Paramita M Ghosh

http://www.w3.org/2001/XMLSchema#string

Roble G Bedolla

http://www.w3.org/2001/XMLSchema#string

Shazli N Malik

http://www.w3.org/2001/XMLSchema#string

Thomas J Prihoda

http://www.w3.org/2001/XMLSchema#string

Yu Wang

http://www.w3.org/2001/XMLSchema#string

P304

119-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1677/ERC.1.00835

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7946535

http://www.w3.org/2001/XMLSchema#string

P698

15788644

http://www.w3.org/2001/XMLSchema#string